IMPROvER

IMPROvER identifies stabilizing variants of integral membrane proteins to improve their stability for accurate structure determination.


Key Features:

  • Integrated prediction approaches: Combines deep-sequence analysis, model-based predictions, and data-driven approaches for variant selection.
  • In silico testing: Evaluates predictions using known stability data.
  • In vitro validation: Experimental tests were performed on membrane protein targets with 7, 11, and 16 transmembrane helices.
  • Ranking-based selection: Focuses on highest ranked sites across methods to prioritize variants.
  • Synergistic improvement: Combining independent approaches yields a fourfold improvement in selection success over random choice.
  • Low-overlap complementarity: Low overlap between method predictions provides complementary candidate coverage.
  • General applicability: Applicable to selection of stabilizing variants across helical membrane proteins.

Scientific Applications:

  • Structure determination: Selecting stabilizing variants to enable accurate structure determination of integral membrane proteins.
  • Mutagenesis prioritization: Prioritizing mutagenesis targets to reduce experimental screening workload.
  • Prediction benchmarking: Assessing prediction performance via in silico testing against known stability datasets.
  • Helical membrane protein stabilization: Supporting stabilization efforts for proteins with 7, 11, and 16 transmembrane helices.

Methodology:

Integrates deep-sequence analysis, model-based predictions, and data-driven approaches; performs in silico testing against known stability data; ranks and combines independent method predictions to select highest ranked sites.

Topics

Details

Tool Type:
web application
Added:
1/18/2021
Last Updated:
3/18/2021

Operations

Publications

Harborne SPD, Strauss J, Boakes JC, Wright DL, Henderson JG, Boivineau J, Jaakola V, Goldman A. IMPROvER: the Integral Membrane Protein Stability Selector. Scientific Reports. 2020;10(1). doi:10.1038/s41598-020-71744-x. PMID:32938971. PMCID:PMC7495477.

PMID: 32938971
PMCID: PMC7495477
Funding: - Biotechnology and Biological Sciences Research Council: BB/M021610/1, White Rose DTP postgraduate fellowship - Medical Research Council: proximity-to-discovery - H2020 European Institute of Innovation and Technology: Marie Skłodowska-Curie grant 722687